BeStock  
Stocks › Biotechnology › GMAB

Genmab GMAB

US equityMarket cap rank #628Biotechnology
$50.60 −$0.75 (-1.46%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $50.02 -1.15%
Open$51.57
Prev close$51.35
Day range$50.24 – $51.72
Volume2.90M
Market cap$31.20B
P/E (TTM)43.2
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.19B+16.1% YoY
Operating profit$441.00M-3.9% YoY
Net profit$342.00M-14.7% YoY
Diluted EPS$0.55-14.7% YoY
Free cash flow$509.00M-4.7% YoY
Operating cash flow$520.00M

Revenue, last 8 quarters

$923.0MDec '24$715.0MMar '25$925.0MJun '25$1.0BSep '25$1.1BDec '25$896.0MMar '26$1.2BJun '26$1.2BSep '26

Net profit, last 8 quarters

$552.0MDec '24$195.0MMar '25$336.0MJun '25$401.0MSep '25$31.0MDec '25$53.0MMar '26$303.0MJun '26$342.0MSep '26

Diluted EPS by quarter

0.85Dec '240.31Mar '250.54Jun '250.65Sep '250.05Dec '250.08Mar '260.49Jun '260.55Sep '26

Free cash flow by quarter

$360.0MDec '24$257.0MMar '25$52.0MJun '25$534.0MSep '25$288.0MDec '25$-2.0MMar '26$48.0MJun '26$509.0MSep '26

Annual revenue

$1.7BFY20$1.3BFY21$2.1BFY22$2.4BFY23$3.1BFY24$3.7BFY25

Profitability & balance sheet

Gross margin92.7%
Operating margin30.6%
Net margin17.0%
Return on equity12.1%
Return on assets7.3%
Return on invested capital11.1%
Current ratio2.45
Liabilities / assets51.0%
Cash & investments$1.86B
Total debt$5.17B
Net cash (debt)-$3.31B
Free cash flow / sales19.6%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • DARZALEX$751.00M 63.3%
  • Kesimpta$149.00M 12.6%
  • Net product sales$149.00M 12.6%
  • Other$55.00M 4.6%
  • TEPEZZA$36.00M 3.0%
  • Collaboration revenue$17.00M 1.4%
  • Reimbursement revenue$15.00M 1.3%
  • License revenue$10.00M 0.8%
  • Milestone revenue$5.00M 0.4%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $1.19B $1.16B $896.00M $3.72B $1.06B
Total Operating Revenue $1.19B $1.16B $896.00M $3.72B $1.06B
Cost of Revenue $88.00M $84.00M $65.00M $238.00M $81.00M
Gross Profit $1.10B $1.07B $831.00M $3.48B $977.00M
Operating Expense $658.00M $664.00M $606.00M $2.23B $734.00M
Selling and Admin Expenses $196.00M $205.00M $166.00M $626.00M $208.00M
Research & Development $451.00M $459.00M $440.00M $1.61B $535.00M
Depreciation & Amortization & Depletion $11.00M – – – –
-Depreciation & Amortization $11.00M – – – –
Operating Profit $441.00M $407.00M $225.00M $1.25B $243.00M
Net Non-Operating Interest Income (Expense) -$86.00M -$74.00M -$98.00M $77.00M $4.00M
Non-Operating Interest Income $25.00M $36.00M $14.00M $138.00M $48.00M
Non-Operating Interest Expense $111.00M $110.00M $112.00M $61.00M $44.00M
Other Income (Expense) -$1.00M -$38.00M -$53.00M -$123.00M -$192.00M
Gain on Sale of Security $9.00M -$6.00M -$8.00M $62.00M -$7.00M
Special Income (Charges) -$10.00M -$32.00M -$45.00M -$185.00M -$185.00M
-Less:Restructuring and Mergern & Acquisition $10.00M $32.00M $45.00M $185.00M $185.00M
Pretax Profit $354.00M $295.00M $74.00M $1.20B $55.00M
Tax $12.00M -$8.00M $21.00M $241.00M $24.00M
Net Profit $342.00M $303.00M $53.00M $963.00M $31.00M
Profit from Continuing Operations $342.00M $303.00M $53.00M $963.00M $31.00M
Net Income to Parent Company $342.00M $303.00M $53.00M $963.00M $31.00M
Net Income to Common Stockholders $342.00M $303.00M $53.00M $963.00M $31.00M
Basic EPS $0.56 $0.49 $0.08 $1.55 $0.06
Diluted EPS $0.55 $0.49 $0.08 $1.54 $0.05

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $12.94B $12.52B $12.38B $12.87B $12.87B
Total Current Assets $3.19B $2.80B $2.57B $2.89B $2.89B
Cash and Cash Equivalents & Short-Term Investments $1.86B $1.50B $1.52B $1.72B $1.72B
-Cash and Cash Equivalents $1.86B $1.50B $1.52B $1.72B $1.72B
Receivables $1.30B $1.28B $1.03B $1.15B $1.15B
-Accounts Receivable $1.24B $1.21B $968.00M $1.11B $1.11B
-Taxes Receivable $57.00M $68.00M $63.00M $40.00M $40.00M
Inventory $30.00M $18.00M $21.00M $18.00M $18.00M
Total Non-Current Assets $9.75B $9.71B $9.80B $9.99B $9.99B
Net PPE $314.00M $254.00M $265.00M $280.00M $280.00M
-Gross PPE $314.00M $254.00M $265.00M $437.00M $437.00M
Investments and Advances $39.00M $36.00M $40.00M $37.00M $37.00M
Goodwill and Other Intangible Assets $9.20B $9.23B $9.30B $9.48B $9.48B
-Goodwill $355.00M $355.00M $355.00M $355.00M $355.00M
-Other Intangible Assets $8.84B $8.87B $8.95B $9.12B $9.12B
Non-Current Deferred Assets $173.00M $173.00M $173.00M $171.00M $171.00M
Other Non-Current Assets $25.00M – $22.00M – –
Total Liabilities $6.60B $6.56B $6.69B $7.03B $7.03B
Total Current Liabilities $1.30B $1.14B $1.18B $1.43B $1.43B
Payables $932.00M $807.00M $861.00M $1.11B $1.11B
-Total Tax Payable $0.00 $0.00 $0.00 $43.00M $43.00M
-Other Payable $932.00M $807.00M $861.00M $1.07B $1.07B
Short-Term Debt and Capital Lease Obligation $348.00M $312.00M $293.00M $291.00M $291.00M
-Current Debt $318.00M $294.00M $275.00M $273.00M $273.00M
-Current Capital Lease Obligation $30.00M $18.00M $18.00M $18.00M $18.00M
Current Deferred Liabilities $19.00M $21.00M $24.00M $24.00M $24.00M
Total Non-Current Liabilities $5.30B $5.42B $5.52B $5.60B $5.60B
Long Term Accounts Payable and Other Payables $7.00M $5.00M $5.00M $5.00M $5.00M
Long Term Debt and Capital Lease Obligation $4.85B $4.96B $5.06B $5.14B $5.14B
-Long Term Debt $4.67B $4.84B $4.93B $5.00B $5.00B
-Long Term Capital Lease Obligation $176.00M $120.00M $125.00M $134.00M $134.00M
Non-Current Deferred Liabilities $447.00M $452.00M $453.00M $459.00M $459.00M
Total Equity $6.33B $5.96B $5.68B $5.85B $5.85B
Stockholders' Equity $6.33B $5.96B $5.68B $5.85B $5.85B
Capital Stock $10.00M $10.00M $10.00M $10.00M $10.00M
-Common Stock $10.00M $10.00M $10.00M $10.00M $10.00M
Additional Paid-In Capital $1.94B $1.92B $1.92B $1.92B $1.92B
Retained Earnings $4.80B $4.42B $4.09B $4.10B $4.10B
Gains/Losses Not Affecting Retained Earnings -$414.00M -$397.00M -$340.00M -$181.00M -$181.00M
Non Current Accounts Receivables – $24.00M – $22.00M $22.00M
-Short Term Investments – – – $0.00 $0.00
-Accumulated Depreciation – – – -$157.00M -$157.00M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $520.00M $51.00M $3.00M $1.19B $301.00M
Net cash flow from continuing operations $520.00M $51.00M $3.00M $1.19B $301.00M
Net Income from Continuing Operations $354.00M $295.00M $74.00M $1.20B $55.00M
Gain/Loss from Continuing Operations -$9.00M $6.00M $8.00M -$62.00M $7.00M
Depreciation & Depletion & Amortization $27.00M $26.00M $29.00M $71.00M $21.00M
Other Non-Cash Items $86.00M $74.00M $98.00M -$77.00M -$4.00M
Change in Working Capital $26.00M -$267.00M -$113.00M $225.00M $253.00M
-Change in Receivables -$12.00M -$259.00M $158.00M -$166.00M -$42.00M
-Change in Inventory -$38.00M $3.00M -$3.00M -$9.00M -$4.00M
-Change in Payables and Accrued Expense $84.00M -$8.00M -$261.00M $400.00M $299.00M
-Change In Other Working Capital -$8.00M -$3.00M -$7.00M – –
Net cash flow from investing -$9.00M $2.00M -$9.00M -$5.64B -$5.57B
Net Cash Flow from Continuing Investing Activities -$9.00M $2.00M -$9.00M -$5.64B -$5.57B
Net PPE Purchase and Sale -$4.00M -$2.00M -$5.00M -$37.00M -$13.00M
Net Intangibles Purchase and Sale -$7.00M -$1.00M $0.00 -$18.00M $0.00
Net Investment Purchase and Sale $7.00M $0.00 -$4.00M $1.63B $1.66B
Financing Cash Flow -$151.00M -$75.00M -$177.00M $4.79B $5.23B
Net Cash Flow from Continuing Financing Activities -$151.00M -$75.00M -$177.00M $4.79B $5.23B
Net Issuance Payments Of Debt -$164.00M -$65.00M -$69.00M -$13.00M -$2.00M
Net Common Stock Issuance $0.00 $0.00 -$96.00M $5.07B $5.50B
Proceeds from Stock Option Exercised $13.00M $1.00M $2.00M $23.00M $7.00M
Net Other Financing Charges $0.00 -$11.00M -$14.00M -$291.00M -$276.00M
Ending Cash Balance $1.86B $1.50B $1.52B $1.72B $1.72B
Net Change in Cash $360.00M -$22.00M -$183.00M $332.00M -$42.00M
Beginning Cash Balance $1.50B $1.52B $1.72B $1.38B $1.76B
Effect of Exchange Rate Changes -$3.00M $4.00M -$11.00M $3.00M -$4.00M
Free Cash Flow $509.00M $48.00M -$2.00M $1.13B $288.00M
Net Business Purchase and Sale – – – $0.00 $0.00
Net Other Investing Changes – – – -$7.22B –

Discussion

No comments yet — be the first to weigh in on GMAB.

Sign in to join the discussion.

Scroll to Top